Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Efficacy and Intermediate Endpoint Biomarkers Orientation Meeting
Research Institute of Fox Chase Cancer Center, Philadelphia, PA, United States
Search grants from Research Institute of Fox Chase Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Novel Modulators of Alcohol Induced Metabolic and Liver Injury
Hormonal and Zinc Regulation of Prostate M-Aconitase
Motivating Smokers to Reduce Their Child's Ets Exposure
Synaptic Interactions of Baro- and Chemoreceptor Neurons
Characteristics of Multiple Drug Resistance
Recently added grants:
Analgesic and subjective effects of terpenes administered alone and in combination with THC: Potential THC- and opioid-sparing effects of myrcene and -caryophyllene
New Murine Models for Study of Atrophic Fracture Nonunion
Common and rare sequence variants in breast cancer risk
Control of quiescence and outgrowth in latent breast preneoplastic cells
MerTK and the Innate Immune Response to Melanoma
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
261201200015I-0-26100001-1
Application #
8556617
Study Section
Project Start
2012-09-20
Project End
2014-09-19
Budget Start
Budget End
Support Year
Fiscal Year
2012
Total Cost
$4,495
Indirect Cost
Institution
Name
Research Institute of Fox Chase Cancer Center
Department
Type
DUNS #
064367329
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Comments
Be the first to comment on this grant
